Blog

Company News

Industry Trends

Laws Regulations

All Categories >

14

2025-11

HiXpan® Cell Culture Additive | Meets Drug Regulatory Submission Requirements, Setting a New Benchmark for Industry Compliance

Cell culture supplements are chemically defined or animal-free additives used in cell culture to replace traditional animal sera, such as fetal bovine serum, with the aim of reducing batch-to-batch variability, minimizing contamination risks, and enhancing experimental reproducibility. Their composition typically includes growth factors, carrier proteins, trace elements, and other components, making them suitable for applications in vaccine production, biopharmaceuticals, regenerative medicine, and other fields.

2025-11-14

He Yousheng

06

2025-11

One-Stop Comprehensive Solution for In Vitro Immunogenicity Assessment

With the rapid advancement of biotechnology-based therapeutics—including therapeutic proteins, monoclonal antibodies, and cell and gene therapy products—immunogenicity assessment has become an indispensable and critical component of drug development and clinical safety monitoring. Immunogenicity refers to the phenomenon in which the body recognizes therapeutic protein drugs as foreign antigens, thereby triggering an immune response. Unnecessary or unexpected immune reactions can severely compromise a drug’s safety and efficacy.

2025-11-06

He Yousheng

04

2025-11

Application Showcase | Hycells One-Stop Comprehensive NK Cell Solution

Shanghai Hycells Biotechnology Co., Ltd. is a high-tech enterprise specializing in research on primary immune cells and stem cells. The company has established an integrated technology platform covering both immune cells and mesenchymal stem cells (MSCs), dedicated to providing customers with end-to-end cell-based solutions.

2025-11-04

He Yousheng

04

2025-11

Call for Papers | Application Process Now Open for 2025 SCI Paper Awards

On the journey of exploring life sciences, every breakthrough is worth celebrating, and every bit of support is worthy of gratitude. Hycells has consistently stood by your side, providing high-quality sample services, technical support, and specialized products to empower your research and development efforts. To express our heartfelt appreciation for the trust and support of both new and longstanding customers, Hycells is proudly launching a paper submission reward program—offering exclusive rewards as a token of our gratitude and paying tribute to every researcher!

2025-11-04

He Yousheng

20

2025-10

One-Stop Complete Solution for γδ T Cell Culture

As an emerging immunotherapy, γδ T-cell immunotherapy has become a new research hotspot due to its unique anti-tumor advantages. γδ T cells exert their anti-tumor effects primarily by secreting pro-apoptotic molecules and inflammatory cytokines, as well as through TCR-dependent mechanisms. Numerous clinical studies have demonstrated that γδ T-cell immunotherapy exhibits good tolerability and efficacy.

2025-10-20

He Yousheng

20

2025-10

Exhibition Invitation | The Inaugural Intelligent Technologies Forum for Drug Discovery and the WeMol User Conference

To mark the 10th anniversary of Weixin Computing, we cordially invite all WeMol platform users and drug discovery experts to gather in Shanghai for the inaugural Intelligent Technologies in Drug Discovery Forum and WeMol User Conference, to be held on November 8, 2025. With the theme “A New Paradigm for AI-Driven Drug Discovery: From Technology Leadership to Value Creation,” the event will feature presentations by numerous distinguished guests showcasing real-world user case studies, a focused exchange on cutting-edge applications of AI-assisted drug discovery, and an exploration of innovative R&D models that integrate computational and experimental approaches. Zhang Yingbo, Head of the Biotechnology Division at Shanghai Hycells, has also been invited to attend this conference.

2025-10-20

He Yousheng
< 1234...20 >